PENG and LFCN Block Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty
Launched by MINIA UNIVERSITY · Dec 7, 2022
Trial Information
Current as of May 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two types of nerve blocks, the PENG block and the lateral femoral cutaneous nerve block, to manage pain after total hip replacement surgery. The goal is to see how well these methods work compared to the traditional lumbar plexus block in providing relief from postoperative pain. Since some patients may have restrictions on using certain types of anesthesia due to medications they take, this study aims to find safer and effective alternatives.
To participate in this trial, you need to be between 30 and 70 years old and in good health (classified as ASA physical status I to III). Certain conditions, like severe obesity, bleeding disorders, psychiatric issues, or a history of opioid dependence, would disqualify you. If you decide to join, you can expect to receive one of the three types of nerve blocks during your surgery and will be monitored for pain relief and any side effects afterward. This could be an important step in finding better pain management solutions for hip surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (ASA) physical status I to III scheduled for hip surgery aged (30-70) years
- Exclusion Criteria:
- • Drug allergy,
- • Morbid obesity (BMI \>40 kg/m2),
- • Coagulopathy,
- • Psychiatric disorder,
- • Opioid dependence,
- • Patient refusal to give informed consent.
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minya, Minia, Egypt
Patients applied
Trial Officials
hassan m. hetta, lecturer
Principal Investigator
Minia University, faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials